Real-World Outcomes of Induction Chemotherapy With or Without Low-Dose Nivolumab for Stage III Non-Small Cell Lung Cancer Ineligible for Up-Front Local Therapy: A Propensity Score-Matched AnalysisJCO GLOBAL ONCOLOGYIF32025-03-010OA
Moderate and severe iron deficiency anaemia responds better to oral iron therapy than mild iron deficiency anaemia in Crohn's Disease patients: a prospective study in a resource-limited settingJOURNAL OF CROHNS & COLITISIF8.72025-01-220PRE
Ultra-low dose nivolumab added to dose-dense, cisplatin-based neoadjuvant chemotherapy in locally advanced, borderline operable triple negative breast cancer: A matched case-control studyCANCER RESEARCHIF16.62024-05-020PRE
The BRCA mutation spectrum among breast and ovarian cancers in India: highlighting the need to screen BRCA1 185delAG among South IndiansEUROPEAN JOURNAL OF HUMAN GENETICSIF4.62024-03-281PRE
Real-world outcomes with induction systemic therapy for stage III in eligible for upfront local therapy: Pre vs post immunotherapy era in a tertiary referral centreANNALS OF ONCOLOGYIF65.42023-11-010PRE
Adult renal Ewing's sarcoma/primitive neuroectodermal tumor: A 20-year retrospective review of molecular histopathological profiles, and clinical outcomesANNALS OF ONCOLOGYIF65.42023-11-010PRE
Low dose nivolumab with TKI in advanced HCC: Real world outcomes from IndiaANNALS OF ONCOLOGYIF65.42023-06-010OA
Safety, tolerability, and efficacy of total neoadjuvant therapy for adult patients with locally advanced high-risk rectal adenocarcinoma: Retrospective real-world data from South IndiaANNALS OF ONCOLOGYIF65.42020-07-010OAAI